IRMD vs RCL · P/E 51, rev $42.4M vs P/E 26, rev $9.28B
Iradimed Co (IRMD) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the IRMD and RCL stock pages for the full models.
Not investment advice.